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INTRODUCTION
Psoriasis is a chronic, immune-mediated inflammatory skin disease. It ranges in severity from a few scattered red, scaly plaques to involvement of almost the entire body surface. It may progressively worsen with age, or wax and wane in its severity; the degree of severity depends on inheritance and environmental factors (Lebwohl, 2003) . Psoriasis causes considerable psychosocial disability and has a major impact on patients' quality of life (Rapp et al., 1999) . The cost to both patients and health-care systems is high (Javitz et al., 2002) . Psoriasis is associated with cardiovascular disease, depressive illness, and psoriatic arthritis . The causes of psoriasis are not fully understood, but a number of risk factors are recognized, including family history and environmental risk factors, such as smoking, stress, obesity, and alcohol consumption (Huerta et al., 2007) .
Psoriasis is estimated to affect about 2-4% of the population in western countries Gelfand et al., 2005b; Kurd and Gelfand, 2009 ). Important factors in the variation of the prevalence of psoriasis include age, gender, geography, and ethnicity, probably due to genetic and environmental factors. Higher prevalence rates have been reported at higher latitudes, and in Caucasians compared with other ethnic groups (Farber and Nall, 1998) . In addition, the wide variation in prevalence estimates may be influenced by aspects of psoriasis such as its remitting-relapsing course, diversity of clinical presentations , and variation in severity . Aspects of study design may also be important. These include different definitions of prevalence, case definitions (Gelfand et al., 2005b) , sampling frames and methods, and age groups studied.
Although several studies, dating back to the 1960s-1970s, have reported the prevalence of psoriasis (Lomholt, 1964; Hellgren, 1967; Rea et al., 1976; Johnson and Roberts, 1978) , incidence studies are few, probably because of the difficulty in accurately identifying and documenting such cases.
Despite a number of narrative reviews of the epidemiology of psoriasis (Farber and Nall, 1998; Plunkett and Marks, 1998; Christophers, 2001; Naldi, 2004; Neimann et al., 2006; Gudjonsson and Elder, 2007; Chandran and Raychaudhuri, 2010) , a systematic review has not been performed. Furthermore, many of the earlier reviews included studies that combined data from general population, hospital, or dermatology clinics with no clear distinction in the results, and no review has looked at the variation of psoriasis according to age and method of case definition. Therefore, the aim of this systematic review was to evaluate the prevalence and incidence of psoriasis from studies in the general population and to explore variations in epidemiology on the basis of geographical location, age, and, where possible, on study design (survey, primary-care data, or other registries), case definition (self-reported, physician's, or dermatologist's diagnosis), and definition of prevalence (lifetime, period, or point prevalence). Figure S1 online summarizes the results of the search strategy. Papers were mainly excluded from the search because (i) they did not provide any measure of prevalence or incidence of psoriasis, (ii) subjects were identified from dermatology clinics, and (iii) the study focused on specific subgroups of the population. In all, we identified 46 studies that reported on the prevalence of psoriasis (Supplementary Tables S1-S3 online) and 7 studies that focused on the incidence of psoriasis in the general population (Table 1) .
RESULTS

Supplementary
Prevalence of psoriasis
Most studies of the prevalence of psoriasis were conducted in Europe or United States, but there were also studies from Australia, China, Egypt, Latin America, Sri Lanka, Taiwan, and Tanzania. Key differences in prevalence rates depended on whether the study population included only children, only adults, or individuals of all ages, as well as on the underlying age and sex structure of the whole population. Further variation was related to the following: the definition of prevalence, such as point (15 studies), period (9 studies), or lifetime (19 studies); methodology used, such as survey (30 studies), administrative database (11 studies), or insurance database (4 studies); and case definition, such as self-report, physician's, or dermatologist's diagnosis.
Prevalence of psoriasis in children
Six studies reported the prevalence of psoriasis in children (defined as those aged o18 years) in Europe or Asia (Figure 1 ). In general, the prevalence of psoriasis in children was up to 0.71% in Europe (Augustin et al., 2010) and almost absent in Asia (Yang et al., 2007; Chen et al., 2008) . One exception was a study of 13-to 14-year-old children in Italy that found a lifetime prevalence of dermatologist diagnosed psoriasis of 2.15% (95% confidence interval (CI): 1.59-2.61) (Naldi et al., 2009) . A German study, based on an insurance database and confined to those aged under 18 years, reported a low overall prevalence of psoriasis in children (0.71% (95% CI: 0.68-0.74)) and an increasing prevalence with age (0.37% for 0-9 years and 1.01% for 10-18 years) (Augustin et al., 2010) (Supplementary Table S1 online). Not surprisingly, studies based on lifetime prevalence generally yielded higher estimates than those based on point prevalence.
Prevalence of psoriasis in adults
Studies of the prevalence of psoriasis in adults (Figure 2 ) yielded higher prevalence estimates than studies in children. However, there appeared to be little consistency within or between countries. In Europe, the United Kingdom had one of the lowest and most consistent estimates, probably due to the same methodology (primary-care database). Here, prevalence of psoriasis in adults was estimated as 1.30% (95% CI:1.21-1.39) (O'Neill and Kelly, 1996) , 2.60% (95% CI: 2.47-2.78) (Kay et al., 1999) , and 2.20% (95% CI: 2.19-2.21) (Seminara et al., 2011) , respectively. A study from Croatia in the late 1980s reported a psoriasis prevalence (1.21% (95% CI: 0.95-1.47)) similar to that of the United Kingdom (Barisic-Drusko et al., 1989) . Other countries, in North-East and South Europe, reported higher values than the United Kingdom, specifically of 3.73% (95% CI: 3.13-4.32) in Denmark (Brandrup and Green, 1981) , 4.82% (95% CI: 4.47-5.17) (Kavli et al., 1985) and 8.50% (95% CI: 8.03-8.97) in Norway (Bo et al., 2008) , 3.10% (95% CI: 2.54-3.66) in Italy , and 5.20% (95% CI: 4.68-5.72) in France (Wolkenstein et al., 2009) .
Estimates of prevalence of psoriasis in Australia ranged from 2.30% (95% CI: 1.39-3.21) to 6.6% (95% CI: 5.4-7.9) (Quirk, 1979; Kilkenny et al., 1998; Plunkett et al., 1999) , whereas rates in United States ranged from 2.2% (95% CI: 2.0-2.4) to 3.15% (95% CI: 2.60-3.70) Kurd and Gelfand, 2009 ) and were similar to those from United Kingdom. Exceptions were two studies in the United States, one collecting data on African Americans and the other study from two medical insurance databases, which reported a prevalence of 1.3% (95% CI: 0.7-1.8) (Gelfand et al., 2005a) and 0.91% (95% CI: 0.90-0.92) and 1.06% (95% CI: 1.05-1.07), respectively (Robinson et al., 2006) . Qureshi et al. (2009) reported a prevalence of psoriasis (2.58% (95% CI: 2.47-2.69)) only in women, which was consistent with other studies conducted in the United States Kurd and Gelfand, 2009) .
Only in the reports from Europe it appeared that studies based on self-reported diagnoses had higher prevalence rates than physicians' diagnoses ( (Brandrup and Green, 1981; Kavli et al., 1985; O'Neill and Kelly, 1996; Kay et al., 1999; Naldi et al., 2004; Bo et al., 2008; Wolkenstein et al., 2009; Seminara et al., 2011) ; Supplementary Table S2 online).
Prevalence of psoriasis for individuals of all ages
On examining individuals of all ages, in Europe, prevalence rates varied between 0.73% (in Scotland) and 2.9% (in Italy). However, although most of the studies reported a prevalence above 1%; specifically 2.00% (95% CI: 1.86-2.14) in Sweden (Hellgren, 1967) , 1.10% (95% CI: 0.11-2.09), 1.40% (95% CI: 0.94-1.86), and 1.40% (95% CI: 1.18-1.62) in Norway (Braathen et al., 1989; Falk and Vandbakk, 1993) , 2.84% (95% CI: 2.53-3.15) in Denmark (Lomholt, 1964) , 1.58% (95% CI: 0.00-3.35) in Yugoslavia (Arzensek et al., 1984) , 1.48% (95% CI: 1.20-1.80), 1.52% (95% CI: 1.51-1.53), and 1.87% (95% CI: 1.89-1.91) in United Kingdom (Nevitt and Hutchinson, 1996; Gelfand et al., 2005b; Seminara et al., 2011) , 1.43% (95% CI: 1.23-1.63) in Spain (Ferrandiz et al., 2001) , 2.90% (95% CI: 2.39-3.41) in Italy (Saraceno et al., 2008) , and 2.00% (95% CI: 1.98-2.20) and 2.53% (95% CI: 2.50-2.56) in Germany (Schlander et al., 2008; Augustin et al., 2010) , two studies from Scotland and United Kingdom showed lower estimates of psoriasis equal to 0.73% (95% CI: 0.69-0.76) (Simpson et al., 2002) and 0.80% (95% CI: 0.78-0.82) (Gillard and Finlay, 2005) , respectively. The only study from European Russia reported a prevalence of 0.72% (95% CI: 0.70-0.74) (Osmanova, 1985) . Rates in United States varied from 0.7% to 2.6%. However, whereas Johnson and Roberts (1978) and Koo (1996) reported rates similar to those of Europe (1.43% (95% CI: 1.27-1.59) and 2.60% (95% CI: 2.43-2.77) respectively), Javitz et al. (2002) showed a prevalence of 0.70% (95% CI: 0.67-0.73). The prevalence rates reported in Latin Americans-Indians, from Africa (Egypt and Tanzania) and Asia (China, Sri Lanka and Taiwan) varied from no cases detected to estimates below 0.5% (Convit, 1963; Yip, 1984;  Cooperative Psoriasis Study Group, 1986; Gibbs, 1996; Perera et al., 2000; Abdel-Hafez et al., 2003; Tsai et al., 2011) .
Prevalence of psoriasis by gender
There was no agreement about whether the prevalence of psoriasis differed between men and women (Supplementary Tables S1-S4 online). No differences in the frequency of psoriasis between genders were found in Taiwanese children (Yang et al., 2007; Tsai et al., 2011) , in the United States and Norway in adults (Kavli et al., 1985; Bo et al., 2008; Kurd and Gelfand, 2009) , and in the United States, United Kingdom, Norway, Spain, Scotland, and Taiwan in individuals of all ages combined (Braathen et al., 1989; Ferrandiz et al., 2001; Javitz et al., 2002; Simpson et al., 2002; Gelfand et al., 2005b; Chang et al., 2009; Seminara et al., 2011; Tsai et al., 2011) . Other studies reported a slightly higher prevalence of psoriasis in female subjects than male subjects in Swedish children (0.5% vs 0.1%) (Larsson and Liden, 1980) and in Germany (0.76% vs 0.66%) (Augustin et al., 2010) ; in the United States (2.5% vs 1.9% with an odds ratio ¼ 1.37 (95% CI: 1.14-1.64)) and in Norway (1.6% vs 1.2% (Lapps) and 1.4% vs 0.9% (non-Lapps)) (Falk and Vandbakk, 1993) in adults and in all ages, respectively. In contrast, psoriasis was more frequent in men than in women in Denmark (4.2% vs 3.3%, not significant) (Brandrup and Green, 1981) and in Australia, where it was reported to be almost twice as high in men as in women (8.9% vs 4.5% (Plunkett et al., 1999) , and in individuals of all ages in Sweden (2.3% vs 1.5%) (Hellgren, 1967) and China (0.17% vs 0.12%) (Cooperative Psoriasis Study Group, 1986 ).
Prevalence of psoriasis by age group
Fourteen studies examined the prevalence (mostly lifetime prevalence) of psoriasis by age. As one would expect, there was an increasing trend with age ( Figure 3 , Supplementary Table S4 online). Psoriasis was uncommon before the age of 9 years, varying from 0% (Norway) to 0.55% (United Kingdom).
In adults (Supplementary Table S4 online), studies from Norway, Scotland, Spain, and Taiwan showed a first peak of psoriasis at either 20-29 or 30-39 years of age (Brandrup and Green, 1981; Kavli et al., 1985; Braathen et al., 1989; Falk and Vandbakk, 1993; Ferrandiz et al., 2001; Simpson et al., 2002; Tsai et al., 2011) , whereas in the remaining studies from the United Kingdom, Germany, Russia, and United States there was an increasing trend with age until around 60 years, after which the prevalence reduced (Osmanova, 1985; Javitz et al., 2002; Stern et al., 2004; Gelfand et al., 2005b; Schlander et al., 2008; Seminara et al., 2011; Tsai et al., 2011) .
Incidence of psoriasis
Seven studies examined the incidence of psoriasis in the general population. These studies were conducted in the United States, the Netherlands, United Kingdom, and Italy. All the studies in the United States, except Setty et al. (2007) , used the Rochester Epidemiology Project database, often looking at different groups of the population (children or adults or all ages) and different time periods.
Incidence of psoriasis in children
There was only one study of the incidence of psoriasis in children; this was conducted in the United States over a 30-year period (Tollefson et al., 2010) (Table 1 ). It found that the incidence of psoriasis was slightly higher in girls than in boys (43.9/100,000 person-years (95% CI: 37.6-50.2) vs 37.9/ 100,000 person-years (95% CI: 32.2-43.6)), although it was not statistically significant. The data showed a rise in the incidence of psoriasis between 1970 and 2000.
Incidence of psoriasis in adults
Three studies reported the incidence of psoriasis in adults (Table 1) -two from the United States and one from Italy. The two estimates in the United States were similar (78.9/100,000 person-years (95% CI: 75.0-82.9; Icen et al., 2009 ) and 82/100,000 person-years (95% CI: 77-89; Setty et al., 2007) , the last one being confined to women). Icen et al. (2009) found a higher incidence of psoriasis in men than in women (85.5/100,000 person-years vs 73.2/100,000 person-years). Combining the two studies from the United States, which both used the Rochester Epidemiology Project database, it appeared that whereas the incidence was higher in girls than in boys until 18 years of age, thereafter psoriasis affected men more frequently than women. In the same study, data showed an increasing trend in the incidence of psoriasis in adults over a 30-year period (Table 1) (Icen et al., 2009) . The Italian study reported a much higher incidence rate of 230/100,000 personyears in 2005 (Vena et al., 2010) .
Incidence of psoriasis in all ages combined
Finally, three studies examined the incidence of psoriasis in all ages. Bell et al. (1991) , using the Rochester Epidemiology Project database, reported an overall incidence of 59.9/ 100,000 person-years (95% CI: 49. European studies used data from primary-care databases. They reported incidences of 120-130/100,000 person-years (the Netherlands) (Donker et al., 1998) and 140/100,000 personyears (United Kingdom) (Huerta et al., 2007) (Table 1) .
Variation by age and gender
The incidence of psoriasis in children increased with age (from 13.5/100,000 person-years (0-3 years old) to 53.1/100,000 person-years (14-18 years old) (Tollefson et al., 2010) ; Table 2 ). Table 2 summarizes the remaining studies of the incidence of psoriasis by age. Despite higher estimates of psoriasis incidence from the United Kingdom (Huerta et al., 2007) than the United States (Bell et al., 1991; Icen et al., 2009) , all these studies showed a similar trend of increasing psoriasis incidence with age up to 39 years. The incidence of psoriasis then reduced at 40-49 years of age before increasing again with a second peak at around 50-59 years of age in the United Kingdom (Huerta et al., 2007) and around 60-69 years of age in the two studies in United States (Bell et al., 1991; Icen et al., 2009) . Age-specific estimates of incidence decreased toward the end of life.
There was a lack of agreement in the published studies about variation by gender for incidence rates. Although the reported overall incidence was slightly higher in girls compared with boys aged under 18 years (43.9/100,000 personyears vs 37.9/100,000 person-years), this pattern was not constant across all age bands (Tollefson et al., 2010) . Some studies showed a higher incidence in women than in men (Bell et al., 1991; Vena et al., 2010) , whereas others presented the opposite results (Icen et al., 2009; Vena et al., 2010) . When looking at gender by age bands, the two peaks for age at onset in women were more frequently around 20-29 and 50-59 years of age, whereas in men they occurred around 30-39 and 60-69/70-79 years of age (Huerta et al., 2007; Icen et al., 2009) .
DISCUSSION
This systematic review provides a detailed critique of the existing data on the worldwide incidence and prevalence of psoriasis. Comparison between studies was attempted in relation to geography, age, and gender. In addition, we investigated whether observed differences in disease occurrence might have been due to varying study methodologies used, such as types of measure, case definition, and study design.
The results from the systematic review confirmed that psoriasis is a common disease, less common in children and more common in adults; prevalence rates showed a worldwide geographic variation that probably reflects the fact that psoriasis is a complex disease influenced by both genetic and environmental factors. Worldwide, on examining the North and South hemispheres, variation in prevalence of psoriasis appeared to depend on the distance from the equator, with populations located closer to the equator (Egypt, Tanzania, Sri Lanka, Taiwan) being less affected by psoriasis compared with countries more distant from it (Europe and Australia). The higher reported prevalence of psoriasis in Australia was also likely to be influenced by other factors such as European migration and the resulting population genetic case-mix. Within Europe, North-East (Norway, Denmark) and Southern (Italy and France) countries showed higher prevalence estimates compared with the United Kingdom; however, the differences between these studies may relate to different case definition (self-reported vs physician's diagnosis) rather than solely geographic variation. There were no clear conclusions about whether the disease varied according to gender. Hellegren et al., 1967 Braathen 1989 Falk et al., 1993 Falk et al., 1993 Arzensek et al., 1984 Simpson et al., 2002 Nevitt et al., 1996 Gillard et al., 2005 Gelfand et al., 2005 Seminara et al., 2011 Ferrandiz et al., 2001 Saraceno et al., 2008 Schlander et al., 2008 Augustin et al., 2010 Osmanova et al., 1985 Johnson et al., 1978 Koo et al., 1996 Javitz et al., 2002 Convit, 1962 Gibbs et al., 1996 Abdel-Hafez et al., 2003 Perera et al., 2000 Yip, 1984 Study Group, 1986 Tsai et al., 2011 North America
Latin America Africa Asia Cooperative Psoriasis Figure 3 . Studies providing information on the prevalence of psoriasis in all ages. Circle, period prevalence; diamond, not specified; square, lifetime prevalence; triangle, point prevalence.
The main purpose of this investigation, and also the main difference from other reviews, was to analyze only data from the general population and to cluster studies on whether their focus was children, adults, or individuals of all ages. We found that psoriasis was less common in children than in adults; therefore, studies estimating prevalence for all ages showed a much lower rate compared with those calculating the prevalence in adults especially in countries with a high proportion of children and young people.
Other sources of heterogeneity in the results were likely to be due to different methodologies, namely types of measure (point, period, or lifetime prevalence) and case definition (selfreported, physician's, or dermatologist's diagnosis). Point, period, or lifetime prevalence may give different rates, as psoriasis is subject to periods of remission and relapse; however, the variation among studies according to this criterion was present only in the United Kingdom, Germany, and the United States. In contrast, the findings consistently showed differences according to case definition. Specifically, self-reported diagnosis gave higher rates compared with physician's and dermatologist's diagnoses.
Prevalence estimates using data from insurance databases were generally lower than studies based on registries or primary-care databases. This may be because insurance databases likely represented only a proportion of the general population (e.g., employed), but underrepresented other subgroups (e.g., unemployed, retired, and disabled people).
Although there were a number of studies on the prevalence of psoriasis, research on incidence was limited. Incidence appeared to be higher in Europe than in the United States and increased with age. Studies reporting age-specific incidence rates showed a dual peak of psoriasis around 30-39 years of age and a second peak around 50-59 or 60-69 years of age (Bell et al., 1991; Huerta et al., 2007; Icen et al., 2009) . It is believed that the bimodal distribution of psoriasis incidence represents two clinical presentations of the disease, type I (early-onset) and type II (late-onset), which are defined as presenting at p40 and 440 years of age, respectively (Henseler and Christophers, 1985) . Furthermore, on combining the results of the two studies using the Rochester Epidemiology Project database, it appeared that the incidence of psoriasis was higher in females o18 years old, but was higher in males X18 years old (Icen et al., 2009; Tollefson et al., 2010) . The same studies reported an increasing incidence in children and adults over a 30-year period (Icen et al., 2009; Tollefson et al., 2010) . However, it was unclear whether this represented a real increase, probably because of a concomitant increase in risk factors (obesity, stress, psychological conditions) for psoriasis, or improved diagnostic methods, better collection of data, and more awareness of the disease (Tollefson et al., 2010) . Nevertheless, the findings from these two studies cannot be confirmed because of the lack of similar research. It is recommended that future studies focus on the incidence of psoriasis over a long period of time. Unfortunately, we were unable to compare age-standardized prevalence and incidence rates from the studies included in this systematic review, as this level of data was not included in many of the original studies. Comparison of unadjusted rates within countries over time and between countries should be interpreted cautiously if the underlying age composition is likely to differ. Future studies examining the epidemiology of psoriasis should routinely provide information on the prevalence and incidence of psoriasis by age bands and gender in a standardized way to facilitate the comparison of results between different studies.
Studies on the occurrence of psoriasis have contributed to a greater appreciation of its burden and recognition of the role of geography and ethnicity on the likelihood of developing the disease. Epidemiological studies are an important contributor to our understanding of psoriasis, and there is a need for future international research collaborations using standardized methodology to address knowledge gaps that still exist on the disease and potential trends in prevalence and incidence over time.
MATERIALS AND METHODS
Search strategy
Three electronic databases (MEDLINE, EMBASE, and Web of Science) were systematically searched from their respective inception dates to July 2011. The main keywords used were ''psoriasis'' (''psoriases'', ''psorias?s'', ''psoriatic skin'', ''pustulosis''), ''psoriatic arthritis'' (''arthritis, psoriatic'', ''psoriatic arthritis'', ''arthritis psoriatica'', ''psoriatic arthropathy'', ''psoriatic rheumatism'', ''psoriatic polyarthritis''), ''incidence'' (''incident studies'' or ''cohort studies''), and ''prevalence'' (''prevalent studies'' or ''cross-sectional studies''). In the final selection, studies only focusing on psoriatic arthritis were excluded. There were no language restrictions and studies were limited to humans.
Inclusion and exclusion criteria
Inclusion criteria were that all studies collected empirical data on cases of psoriasis from a sample of the general population. Studies estimating prevalence or/and incidence of other skin or autoimmune diseases, but also providing data on psoriasis epidemiology, were included. Conversely, exclusion criteria included studies not carried out on the general population (such as dermatology clinics, data collected from hospital admissions/visits or specific subgroups of the population) and studies not providing sufficient information to calculate prevalence or/and incidence rates for psoriasis.
Data extraction
In the first stage, all study titles and abstracts obtained from the database searches were reviewed for eligibility by one of the authors (RP); papers successfully passing through into the second stage were appraised and those meeting the inclusion criteria were selected for data extraction. The references of all included studies and review articles identified were also screened to identify any additional eligible studies.
Information extracted from each study included citation data (authors, publication year), study design (study-period and setting), population (country, age group), study methods (case definition, case validation), type of prevalence (point, period, or lifetime), and findings (number of patients with psoriasis, number of people at risk, values of the prevalence and/or incidence reported and their 95% CIs). All extracted data were double-checked by a coauthor (DMA) to ensure its accuracy.
Data analysis
Measures of prevalence and/or incidence presented are those reported in the individual studies; however, rates are presented as percentage values for prevalence and rate/100,000 person-years for incidence. Values were checked for potential errors (when possible) on the basis of the number of cases of psoriasis and population sample size. Missing information, such as prevalence and/or incidence rate and CIs were calculated when not reported in the study. However, it was not possible to estimate CIs for some studies because of lack of sufficient information. In addition, negative lower bounds of CIs were replaced by zero.
Results were analyzed by country and age category (children, adult, or all ages). Children were defined as being in the age group o18 years old. Within each country and category, study design (case definition (self-reported vs dermatologist vs general practitioner diagnosis) and type of prevalence (point vs period vs lifetime prevalence)) were explored for possible differences. When multiple studies collected data from the same data set and time period, only the most recent or the most complete articles were reported. When the same study presented measures of prevalence and/or incidence of psoriasis from different databases or populations, all results were reported.
